scholarly journals W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kengo Sasaki ◽  
Tomoyuki Mori ◽  
Namiko Hoshi ◽  
Daisuke Sasaki ◽  
Jun Inoue ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Fecal Sample ◽  
Immunoglobulin A ◽  
Suppressive Effect ◽  
Final Concentration ◽  
Rrna Gene ◽  
Fecal Samples ◽  
Human Intestinal Microbiota ◽  
Vitro Model

AbstractW27 monoclonal immunoglobulin A (IgA) suppresses pathogenic Escherichia coli cell growth; however, its effect on the human intestine remains unclear. We aimed to determine how W27 IgA affects the human colonic microbiota using the in vitro microbiota model. This model was established using fecal samples collected from 12 healthy volunteers; after anaerobic cultivation, each model was found to retain the genera found in the original human fecal samples. After pre-incubating W27 IgA with the respective fecal sample under aerobic conditions, the mixture of W27 IgA (final concentration, 0.5 μg/mL) and each fecal sample was added to the in vitro microbiota model and cultured under anaerobic conditions. Next-generation sequencing of the bacterial 16S rRNA gene revealed that W27 IgA significantly decreased the relative abundance of bacteria related to the genus Escherichia in the model. Additionally, at a final concentration of 5 μg/mL, W27 IgA delayed growth in the pure culture of Escherichia coli isolated from human fecal samples. Our study thus revealed the suppressive effect of W27 IgA on the genus Escherichia at relatively low-concentrations and the usefulness of an in vitro microbiota model to evaluate the effect of IgA as a gut microbiota regulator.

scholarly journals W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota

2021 ◽  
Author(s):  
Kengo Sasaki ◽  
Tomoyuki Mori ◽  
Namiko Hoshi ◽  
Daisuke Sasaki ◽  
Jun Inoue ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Fecal Sample ◽  
Immunoglobulin A ◽  
Aerobic Condition ◽  
Suppressive Effect ◽  
Final Concentration ◽  
Rrna Gene ◽  
Fecal Samples ◽  
Vitro Model

Abstract W27 monoclonal immunoglobulin A (IgA) suppresses pathogenic Escherichia coli cell growth; however its effect on the human intestine remains unclear. We thus aimed to determine how W27 IgA affects the human colonic microbiota using the in vitro microbiota model. This model was established using fecal samples collected from 12 healthy volunteers; after anaerobic cultivation, each model was found to retain the genera found in the original human fecal samples. After pre-incubating W27 IgA with the respective fecal sample in aerobic condition, the mixture of W27 IgA (final concentration, 0.5 µg/mL) and each fecal sample was added to the in vitro microbiota model and cultured under anaerobic condition,. Next-generation sequencing of the bacterial 16S rRNA gene revealed that W27 IgA addition significantly decreased the relative abundance of bacteria related to the genus Escherichia in the model. Additionally, at a final concentration of 5 µg/mL, W27 IgA delayed growth in pure culture of Escherichia coli isolated from human fecal samples. Our study thus revealed the suppressive effect of W27 IgA on the genus Escherichia at relatively low-concentrations and the usefulness of an in vitro microbiota model to evaluate the effect of IgA as a gut microbiota regulator.

Comparative methods for fecal sample storage to preserve gut microbial structure and function in an in vitro model of the human colon

2020 ◽  
Vol 104 (23) ◽  
pp. 10233-10247
Author(s):  
Charlotte Deschamps ◽  
Elora Fournier ◽  
Ophélie Uriot ◽  
Frédérique Lajoie ◽  
Cécile Verdier ◽  
...  
Keyword(s):  
Fecal Sample ◽  
In Vitro Model ◽  
Human Colon ◽  
Structure And Function ◽  
Comparative Methods ◽  
Sample Storage ◽  
Microbial Structure ◽  
Vitro Model ◽  
And Function

scholarly journals An in vitro model of catheter-associated urinary tract infections to investigate the role of uncommon bacteria on the Escherichia coli microbial consortium

2017 ◽  
Vol 118 ◽  
pp. 64-69 ◽  
Author(s):  
Andreia S. Azevedo ◽  
Carina Almeida ◽  
Luciana C. Gomes ◽  
Carla Ferreira ◽  
Filipe J. Mergulhão ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Urinary Tract ◽  
Urinary Tract Infections ◽  
In Vitro Model ◽  
Microbial Consortium ◽  
Vitro Model ◽  
Tract Infections

scholarly journals Two New Point Mutations at A2062 Associated with Resistance to 16-Membered Macrolide Antibiotics in Mutant Strains ofMycoplasma hominis

2001 ◽  
Vol 45 (10) ◽  
pp. 2958-2960 ◽  
Author(s):  
Pio Maria Furneri ◽  
Giancarlo Rappazzo ◽  
Maria Pia Musumarra ◽  
Patrizia Di Pietro ◽  
Lucrezia S. Catania ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Point Mutations ◽  
Mycoplasma Hominis ◽  
23S Rrna ◽  
Macrolide Antibiotics ◽  
Rrna Gene ◽  
In Vitro Exposure ◽  
Mutant Strains ◽  
23S Rrna Gene

ABSTRACT We describe two mutants of Mycoplasma hominis PG-21 which show resistance to 16-membered macrolides but susceptibility to lincosamides, obtained by in vitro exposure to increasing doses of josamycin. The 23S rRNA gene showed that each had a mutation (A2062G and A2062T) corresponding to nucleotide 2062 in Escherichia coli, which was associated with the acquired phenotype.

scholarly journals Effect of Escherichia coli Cytotoxic Necrotizing Factor 1 on Repair of Human Bladder Cell Monolayers In Vitro

1999 ◽  
Vol 67 (7) ◽  
pp. 3657-3661 ◽  
Author(s):  
Michael D. Island ◽  
Xaioling Cui ◽  
John W. Warren
Keyword(s):  
Escherichia Coli ◽  
Bladder Epithelium ◽  
Cell Monolayers ◽  
E Coli ◽  
Cytotoxic Necrotizing Factor ◽  
Bladder Cell ◽  
Bladder Cells ◽  
Vitro Model ◽  
Cytotoxic Necrotizing Factor 1

ABSTRACT We hypothesized that Escherichia coli cytotoxic necrotizing factor 1 (CNF1) might impair migration or proliferation of bladder cells and could potentially interfere with repair of the bladder epithelium. Using experimentally wounded human T24 bladder epithelial cell monolayers as an in vitro model, we found that both the number of T24 cells and the maximum distance they migrated into wounded regions was significantly decreased by bacterial extracts containingE. coli CNF1.

scholarly journals Xylo-oligosaccharides from sugarcane show prebiotic potential in a dynamic computer-controlled in vitro model of the adult human large intestine

2020 ◽  
Vol 11 (2) ◽  
pp. 191-200 ◽  
Author(s):  
K. Venema ◽  
J. Verhoeven ◽  
S. Verbruggen ◽  
D. Keller
Keyword(s):  
In Vitro Model ◽  
Short Chain Fatty Acids ◽  
Rrna Gene ◽  
Microbiota Composition ◽  
Gut Health ◽  
Unidentified Species ◽  
Human Adults ◽  
Computer Controlled ◽  
Vitro Model

The aim of the study was to investigate the prebiotic potential of xylo-oligosaccharides (XOS) from sugarcane in a validated, dynamic, computer-controlled in vitro model of the colon (TIM-2) simulating human adults. In two sets of experiments, each with a different microbiota, 3 different doses of XOS were tested at 1.0 g/day, 1.5 g/day and 3.0 g/day. The in vitro model was run for 72 h, and at the start and subsequently every 24 h samples were taken and analysed for short-chain fatty acids (SCFA) and gut microbiota composition. SCFA were analysed using ion chromatography, whereas microbiota composition was analysed using sequencing of the V3-V4 region of the 16S rRNA gene. XOS showed a similar SCFA production per gram of substrate as the control medium, including butyrate, which is considered to be important for gut health. In both sets of experiments XOS showed a consistent dose-dependent increase in abundance over time of the genus Bifidobacterium, and within that of the species B. adolescentis and an unidentified species (labelled ‘sp.1’). The results show the potential prebiotic effect of XOS from sugarcane, by its capacity to generate butyrate and increase the health-beneficial bifidobacteria.

Sign in / Sign up

Export Citation Format

Share Document